This study compared the correct use of and patient preference for two drug delivery systems (inhalers) in patients with COPD
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
140
Tiotropium via Respimat® device once a day
Indacaterol via Breezhaler® device once a day
Novartis Investigative Site
Goiânia, Goiás, Brazil
Novartis Investigative Site
Belo Horizonte, Minas Gerais, Brazil
Novartis Investigative Site
Belo Horizonte, Minas Gerais, Brazil
Number of Participants Who Correctly Used the Device at the Start of Handling the Device
The correct use of 2 drug delivery systems was measured. Participants were given written instructions prior to the first treatment at day one and a check list was used to report the proper handling of the devices.
Time frame: day 1
Number of Participants Correctly Using the Device After One Week of Handling
The correct use of 2 drug delivery systems was measured. Participants were given written instructions prior to the first treatment at day one and a check list was used to report the proper handling of the devices.
Time frame: day 7
Mean Score of the Feeling of Satisfaction With the Inhaler (FSI-10) Questionnaire
Participants completed the FSI-10 questionnaire to assess their satisfaction with the devices. The questionnaire contained 10 questions. each one with 5 possible answers in a Likert scale from 5 (a lot) to 1 (almost nothing). The total overall satisfaction score ranged from 0 - 50. Higher values indicated greater satisfaction
Time frame: day 7
Number of Participants With Preference for Either Device
Participants answered a single question to determine their device preference.
Time frame: day 7
Number of Participnats With Difficulties Experienced When Handling the Devices
Participants used a patient diary to report difficulties with handling the device. Thirteen difficulty categories were assessed.
Time frame: 1 week
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Novartis Investigative Site
Rio de Janeiro, Rio de Janeiro, Brazil
Novartis Investigative Site
Porto Alegre, Rio Grande do Sul, Brazil
Novartis Investigative Site
Porto Alegre, Rio Grande do Sul, Brazil
Novartis Investigative Site
Florianópolis, Santa Catarina, Brazil
Novartis Investigative Site
Ribeirão Preto, São Paulo, Brazil
Novartis Investigative Site
São Paulo, São Paulo, Brazil
Novartis Investigative Site
São Paulo, São Paulo, Brazil